4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000167
Chairperson & CEO sold 9,500 shares at an average $543.32 ($5,161,576)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
20 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-19 | Sale : show line 2 in the form 10b5-1 | −160 | $534.75 | $85,560 | 333,783 | I |
| 2026-10-19 | Sale : show line 3 in the form 10b5-1 | −360 | $536.36 | $193,088 | 333,423 | I |
| 2026-10-19 | Sale : show line 4 in the form 10b5-1 | −240 | $537.11 | $128,907 | 333,183 | I |
| 2026-10-19 | Sale : show line 5 in the form 10b5-1 | −160 | $538.54 | $86,167 | 333,023 | I |
| 2026-10-19 | Sale : show line 6 in the form 10b5-1 | −880 | $539.79 | $475,012 | 332,143 | I |
| 2026-10-19 | Sale : show line 7 in the form 10b5-1 | −1,800 | $540.63 | $973,133 | 330,343 | I |
| 2026-10-19 | Sale : show line 8 in the form 10b5-1 | −520 | $541.38 | $281,516 | 329,823 | I |
| Open-market sales · 9,500 sh · avg $543.32 · $5,161,576 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-19 | Exercise or conversion : show line 21 in the form 10b5-1 Stock Option | −9,500 | 204,910 | I |
Loading xslF345X06/primarydocument.xml…